San Francisco-University of California at San Francisco(905) — San Francisco, California

San Francisco-University of California at San Francisco(905) is a clinical research site located in San Francisco, California, United States 94115.

Crixeo Clinical Trials Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

San Francisco-University of California at San Francisco(905) has participated in 1 clinical trials.

Therapeutic areas: Parkinson Disease.

Sponsors: VA Office of Research and Development.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in San Francisco

Browse all research sites in California · View every site in San Francisco

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for San Francisco-University of California at San Francisco(905)?

San Francisco-University of California at San Francisco(905) has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has San Francisco-University of California at San Francisco(905) conducted?

San Francisco-University of California at San Francisco(905) has 1 clinical trials on record. Their work covers Parkinson Disease.

Is San Francisco-University of California at San Francisco(905) accredited by Crixeo Clinical Trials?

San Francisco-University of California at San Francisco(905) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about San Francisco-University of California at San Francisco(905)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.